Lucinda Warren

Lucinda Warren

Chief Financial and Business OfficeratCue Biopharma· In the 2025 proxy

Pay in FY2025Cue Biopharma stock -72.0% the same year

Lucinda Warren was paid $801.2K in FY2025 (Dec). Cue Biopharma stock fell 72.0% that year.

Pay$100 in the stock at the end of FY24 → $28
Pay is from the Summary Compensation Table of each Cue Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cue BiopharmaPublic company · 1 yr
    • Chief Financial and Business Officer2025 – Present · 1 yrStock in role -30%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?